These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 7785910

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of recombinant osteopontin on adhesion and migration of P388D1 cells.
    Yamamoto S, Nasu K, Ishida T, Setoguchi M, Higuchi Y, Hijiya N, Akizuki S.
    Ann N Y Acad Sci; 1995 Apr 21; 760():378-80. PubMed ID: 7785922
    [No Abstract] [Full Text] [Related]

  • 3. Structural and functional domains of osteopontin.
    Butler WT.
    Ann N Y Acad Sci; 1995 Apr 21; 760():6-11. PubMed ID: 7785926
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of a signal transduction pathway by osteopontin.
    Lopez CA, Davis RL, Mou K, Denhardt DT.
    Ann N Y Acad Sci; 1995 Apr 21; 760():324-6. PubMed ID: 7540377
    [No Abstract] [Full Text] [Related]

  • 6. Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion.
    Senger DR, Brown LF, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L.
    Ann N Y Acad Sci; 1995 Apr 21; 760():83-100. PubMed ID: 7540380
    [No Abstract] [Full Text] [Related]

  • 7. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y, Tanaka K, Higashikawa F, Yamashita K, Eboshida A.
    Matrix Biol; 2005 Sep 21; 24(6):418-27. PubMed ID: 16005200
    [Abstract] [Full Text] [Related]

  • 8. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.
    Smith LL, Giachelli CM.
    Exp Cell Res; 1998 Jul 10; 242(1):351-60. PubMed ID: 9665832
    [Abstract] [Full Text] [Related]

  • 9. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
    Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L.
    Mol Biol Cell; 1994 May 10; 5(5):565-74. PubMed ID: 7522656
    [Abstract] [Full Text] [Related]

  • 10. Roles of osteopontin in bone remodeling.
    Heinegård D, Andersson G, Reinholt FP.
    Ann N Y Acad Sci; 1995 Apr 21; 760():213-22. PubMed ID: 7540374
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of osteopontin with osteoclast integrins.
    Horton MA, Nesbit MA, Helfrich MH.
    Ann N Y Acad Sci; 1995 Apr 21; 760():190-200. PubMed ID: 7540373
    [Abstract] [Full Text] [Related]

  • 12. Osteopontin: a ligand for the alpha v beta 3 integrin of the osteoclast clear zone in osteopetrotic (ia/ia) rats.
    Hultenby K, Reinholt FP, Heinegård D, Andersson G, Marks SC.
    Ann N Y Acad Sci; 1995 Apr 21; 760():315-8. PubMed ID: 7540376
    [No Abstract] [Full Text] [Related]

  • 13. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF.
    J Cell Biochem; 1995 Apr 21; 57(4):680-90. PubMed ID: 7542253
    [Abstract] [Full Text] [Related]

  • 14. Osteopontin overview.
    Rodan GA.
    Ann N Y Acad Sci; 1995 Apr 21; 760():1-5. PubMed ID: 7540370
    [No Abstract] [Full Text] [Related]

  • 15. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity.
    Hruska KA, Rolnick F, Huskey M, Alvarez U, Cheresh D.
    Endocrinology; 1995 Jul 21; 136(7):2984-92. PubMed ID: 7540546
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, NMR and function of an O-phosphorylated peptide, comprising the RGD-adhesion sequence of osteopontin.
    Pettersson E, Lüning B, Mickos H, Heinegård D.
    Acta Chem Scand (Cph); 1991 Jul 21; 45(6):604-8. PubMed ID: 1764332
    [Abstract] [Full Text] [Related]

  • 17. Osteopontin adhesion receptors on gingival fibroblasts.
    D'Errico JA, Sauk JJ, Prince CW, Somerman MJ.
    J Periodontal Res; 1995 Jan 21; 30(1):34-41. PubMed ID: 7536842
    [Abstract] [Full Text] [Related]

  • 18. Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment.
    van Dijk S, D'Errico JA, Somerman MJ, Farach-Carson MC, Butler WT.
    J Bone Miner Res; 1993 Dec 21; 8(12):1499-506. PubMed ID: 8304052
    [Abstract] [Full Text] [Related]

  • 19. Regulation and function of osteopontin in ras-transformed cells.
    Chambers AF.
    Ann N Y Acad Sci; 1995 Apr 21; 760():101-8. PubMed ID: 7785889
    [Abstract] [Full Text] [Related]

  • 20. A monoclonal antibody against osteopontin inhibits RGD-mediated cell adhesion to osteopontin.
    Bautista DS, Xuan JW, Hota C, Chambers AF, Harris JF.
    Ann N Y Acad Sci; 1995 Apr 21; 760():309-11. PubMed ID: 7785907
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.